Russell Investments Group, Ltd. Harmony Biosciences Holdings, Inc. Transaction History

Russell Investments Group, Ltd.

$66.8 Billion
Q3 2024

A detailed history of Russell Investments Group, Ltd. transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 52,023 shares of HRMY stock, worth $1.77 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

52,023

Previous 7,577 586.59%

Holding current value

$1.77 Million

Previous $228,000 811.4%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$30.0 - $39.95 $1.33 Million - $1.78 Million	44,446 Added 586.59%	52,023 $2.08 Million
Q2 2024 Aug 08, 2024	SELL	$28.81 - $33.01 $760,699 - $871,596	-26,404 Reduced 77.7%	7,577 $228,000
Q1 2024 May 08, 2024	BUY	$29.93 - $35.06 $152,104 - $178,174	5,082 Added 17.59%	33,981 $1.14 Million
Q4 2023 Feb 05, 2024	SELL	$19.2 - $33.78 $349,612 - $615,100	-18,209 Reduced 38.65%	28,899 $933,000
Q3 2023 Nov 13, 2023	BUY	$31.89 - $39.03 $705,215 - $863,109	22,114 Added 88.48%	47,108 $1.54 Million
Q2 2023 Aug 10, 2023	SELL	$30.5 - $37.4 $363,285 - $445,471	-11,911 Reduced 32.27%	24,994 $879,000
Q1 2023 May 09, 2023	SELL	$30.8 - $53.92 $2.55 Million - $4.46 Million	-82,758 Reduced 69.16%	36,905 $1.2 Million
Q4 2022 Feb 08, 2023	SELL	$45.4 - $60.91 $2.85 Million - $3.82 Million	-62,671 Reduced 34.37%	119,663 $6.59 Million
Q3 2022 Nov 04, 2022	BUY	$42.06 - $55.45 $4.73 Million - $6.24 Million	112,474 Added 161.0%	182,334 $8.07 Million
Q2 2022 Jul 29, 2022	BUY	$33.54 - $52.15 $1.92 Million - $2.99 Million	57,304 Added 456.39%	69,860 $3.41 Million
Q1 2022 May 05, 2022	BUY	$33.14 - $51.13 $144,589 - $223,080	4,363 Added 53.25%	12,556 $613,000
Q4 2021 Jan 21, 2022	BUY	$34.09 - $43.91 $79,122 - $101,915	2,321 Added 39.53%	8,193 $348,000
Q3 2021 Nov 08, 2021	BUY	$25.68 - $38.61 $150,792 - $226,717	5,872 New	5,872 $224,000
Q4 2020 Feb 08, 2021	SELL	$31.74 - $51.34 $389,608 - $630,198	-12,275 Closed	0 $0
Q3 2020 Nov 09, 2020	BUY	$30.96 - $44.39 $380,034 - $544,887	12,275 New	12,275 $414,000

Others Institutions Holding HRMY

# of Institutions

242

Shares Held

45.1M

Call Options Held

108K

Put Options Held

49.2K

View Full List

About Harmony Biosciences Holdings, Inc.

Ticker HRMY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,161,400
Market Cap $2.02B
Description
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...

More about HRMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.

Account

Russell Investments Group, Ltd. Harmony Biosciences Holdings, Inc. Transaction History